Riethmüller G - Search Results

1

[Monoclonal antibodies: development and clinical prospects].

Borchmann P, Riethmüller G, Engert A. Borchmann P, et al. Among authors: riethmuller g. Internist (Berl). 2001 Jun;42(6):803-4, 807-14. doi: 10.1007/s001080170123. Internist (Berl). 2001. PMID: 11449627 Review. German. No abstract available.

2

Monoclonal antibodies in cancer therapy.

Gruber R, Holz E, Riethmüller G. Gruber R, et al. Among authors: riethmuller g. Springer Semin Immunopathol. 1996;18(2):243-51. doi: 10.1007/BF00820669. Springer Semin Immunopathol. 1996. PMID: 8908703 Review. No abstract available.

3

Monoclonal antibodies in cancer therapy.

Riethmüller G, Schneider-Gädicke E, Johnson JP. Riethmüller G, et al. Curr Opin Immunol. 1993 Oct;5(5):732-9. doi: 10.1016/0952-7915(93)90129-g. Curr Opin Immunol. 1993. PMID: 8240735 Review.

4

Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.

Riethmüller G, Johnson JP. Riethmüller G, et al. Curr Opin Immunol. 1992 Oct;4(5):647-55. doi: 10.1016/0952-7915(92)90041-c. Curr Opin Immunol. 1992. PMID: 1418733 Review.

5

From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease.

Riethmüller G, Rieber EP, Kiefersauer S, Prinz J, van der Lubbe P, Meiser B, Breedveld F, Eisenburg J, Krüger K, Deusch K, et al. Riethmüller G, et al. Immunol Rev. 1992 Oct;129:81-104. doi: 10.1111/j.1600-065x.1992.tb01420.x. Immunol Rev. 1992. PMID: 1464423 Review. No abstract available.

6

[Monoclonal antibodies--new probes for diagnosis and therapy. Their use as an example of the micrometastasizing of solid tumors].

Schlimok G, Funke I, Bock B, Schweiberer B, Riethmüller G. Schlimok G, et al. Among authors: riethmuller g. Arzneimittelforschung. 1988 Mar;38(3A):435-7. Arzneimittelforschung. 1988. PMID: 3293575 Review. German.

7

The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.

Gruber R, van Haarlem LJ, Warnaar SO, Holz E, Riethmüller G. Gruber R, et al. Among authors: riethmuller g. Cancer Res. 2000 Apr 1;60(7):1921-6. Cancer Res. 2000. PMID: 10766181 Clinical Trial.

8

Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.

Schlimok G, Funke I, Holzmann B, Göttlinger G, Schmidt G, Häuser H, Swierkot S, Warnecke HH, Schneider B, Koprowski H, Riethmüller G. Schlimok G, et al. Among authors: riethmuller g. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8672-6. doi: 10.1073/pnas.84.23.8672. Proc Natl Acad Sci U S A. 1987. PMID: 2446326 Free PMC article.

9

Limitations of the immunocytochemical detection of isolated tumor cells in frozen samples of bone marrow obtained from melanoma patients.

Schadendorf D, Dorn-Beineke A, Borelli S, Riethmuller G, Pantel K. Schadendorf D, et al. Among authors: riethmuller g. Exp Dermatol. 2003 Apr;12(2):165-71. doi: 10.1034/j.1600-0625.2003.120207.x. Exp Dermatol. 2003. PMID: 12702145

10

[Immunopotentiation: aims, ways, results].

Riethmüller G. Riethmüller G. Internist (Berl). 1975 Oct;16(10):466-70. Internist (Berl). 1975. PMID: 54347 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page